Apellis Pharmaceuticals, Inc.APLSNASDAQ

Revenue (LTM)

$1.0B

+28.5% YoY

Net Income (LTM)

$22M

+111.3% YoY

Free Cash Flow

$45M

Revenue CAGR (5Y)

+97.1%

Marginsdeclining

FCFTurned positive

Now profitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	67	75↑13.3%	397↑425.8%	781↑97.0%	1,004↑28.5%
Gross Profit	61	70↑13.7%	338↑384.5%	664↑96.3%	902↑35.8%
Operating Income	-536	-595↓10.9%	-517↑13.0%	-165↑68.1%	55↑133.6%
Net Income	-746	-652↑12.6%	-529↑18.9%	-198↑62.6%	22↑111.3%
EBITDA	-731	-617↑15.6%	-495↑19.8%	-155↑68.8%	70↑145.3%
EPS Diluted	-8.84	-6.15↑30.4%	-4.45↑27.6%	-1.60↑64.0%	0.18↑111.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	640	552↓13.8%	351↓36.4%	411↑17.1%	468↑13.7%
Total Current Assets	824	720↓12.7%	766↑6.5%	789↑3.0%	1,015↑28.6%
Total Assets	882	760↓13.8%	789↑3.8%	885↑12.2%	1,075↑21.5%
Total Current Liabilities	132	168↑27.1%	248↑47.7%	186↓25.1%	324↑74.4%
Total Liabilities	683	590↓13.6%	594↑0.7%	657↑10.5%	705↑7.4%
Total Equity	199	170↓14.5%	195↑14.5%	229↑17.5%	370↑62.0%
Total Debt	210	113↓46.4%	111↓1.6%	470↑323.5%	486↑3.5%
Net Debt	-430	-439↓2.1%	-240↑45.3%	58↑124.3%	19↓68.3%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-563	-514↑8.8%	-595↓15.8%	-88↑85.2%	45↑151.6%
Capital Expenditure	-1	-2↓38.2%	-1↑49.3%	-0↑47.9%	-0↑22.3%
Free Cash Flow	-564	-515↑8.7%	-596↓15.6%	-88↑85.2%	45↑151.0%
Stock-Based Comp	71	91↑28.9%	106↑16.3%	114↑7.7%	0
Net Change in Cash	75	-89↓218.7%	-201↓126.4%	60↑130.0%	55↓8.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance